How is Laminopathy diagnosed?
Diagnosis. Diagnosis is based on suggestive clinical features, the cardiac manifestations, as well as the presence of contractures and an autosomal-dominant hereditary pattern.
What is genetic Test for LMNA mutations?
LMNA gene testing is utilized to confirm a diagnosis of dilated cardiomyopathy in patients with clinically evident disease. Genetic testing allows for early identification and diagnosis of individuals at greatest risk prior to the expression of typical clinical manifestations.
Where are Lamins found?
Lamins A and C are also found inside the nucleus, and researchers believe the proteins may play a role in regulating the activity (expression) of certain genes. The lamin A protein must be processed within the cell before becoming part of the lamina.
What is Lamin A protein and why is it important?
Lamin A/C is a nuclear protein with many functions in cells, such as maintaining a cell’s structural stability, cell motility, mechanosensing, chromosome organization, gene regulation, cell differentiation, DNA damage repair, and telomere protection.
What is LMNA cardiomyopathy?
Cardiomyopathy caused by mutations in LMNA gene is referred to as cardiolaminopathy (LMNA-CMP). The disease is generally characterized by variable extent of ventricular dilation (Bonne et al., 1999; Fatkin et al., 1999) or, less frequently, by left ventricular (LV) non-compaction (Sedaghat-Hamedani et al., 2017).
What does LMNA stand for?
LMNA, also known as Lamin A/C is a protein that in humans is encoded by the LMNA gene. Lamin A/C belongs to the lamin family of proteins.
What chromosome is LMNA on?
The LMNA gene located on chromosome 1q11-q23 encodes the intermediate filament proteins lamins A and C. The lamins are located in the nuclear lamina at the nucleoplasmic side of the inner nuclear membrane and have a structural role in maintaining membrane integrity.
How common is LMNA gene mutation?
LMNA is one of the most frequent genes involved in dilated cardiomyopathy. In the largest study of 324 patients with DCM, prevalence of LMNA mutation was 7.5 % in familial cases and 3.6 % in sporadic cases, although the significance of some variants was unclear (in the absence of segregation in the family).
What is LMNA muscular dystrophy?
LMNA-related congenital muscular dystrophy (L-CMD) is a condition that primarily affects muscles used for movement (skeletal muscles). It is part of a group of genetic conditions called congenital muscular dystrophies, which cause weak muscle tone (hypotonia) and muscle wasting (atrophy ) beginning very early in life.
Where is LMNA gene located?
Is LMNA a gene or protein?
What is LMNA CMD?